Throughout the last three months, 11 analysts have evaluated Taysha Gene Therapies (NASDAQ:TSHA), offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 6 | 0 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 3 | 0 | 0 | 0 |
| 2M Ago | 3 | 2 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $6.82, a high estimate of $9.00, and a low estimate of $5.00. Marking an increase of 36.4%, the current average surpasses the previous average price target of $5.00.
Breaking Down Analyst Ratings: A Detailed Examination
The standing of Taysha Gene...
Login or create a forever free account to read this news
Sign up/Log in